Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1996
09/06/1996WO1996026926A1 Pyrazolotetracyclines
09/06/1996WO1996026921A1 Novel biphenyl derivatives or salts thereof, and anti-inflammatory agents containing the same
09/06/1996WO1996026747A2 Use of amidoamines in ophthalmic compositions
09/06/1996WO1996026734A1 Antiviral combinations of bch-189 and ritonavir
09/06/1996WO1996026730A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment
09/06/1996WO1996026728A2 Use of moxonidine for the treatment of atherosclerosis
09/06/1996WO1996026727A1 Methods of inhibiting ovarian cancer
09/06/1996WO1996026726A1 Pharmaceutical composition for piperidinoalkanol compounds
09/06/1996WO1996026725A1 Method for treating atopic dermatitis and contact dermatitis
09/06/1996WO1996026724A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent
09/06/1996WO1996026723A1 Benzothiopyranoindazoles antitumor agents
09/06/1996WO1996026722A1 Use of isosorbide-5-mononitrate
09/06/1996WO1996026721A1 Remedy for pulmonary heart
09/06/1996WO1996026720A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
09/06/1996WO1996026718A2 Controlled release tablet
09/06/1996WO1996026717A1 Sustained release formulation containing three different types of polymers
09/06/1996WO1996026714A1 Process for the preparation of a solid pharmaceutical dosage form
09/06/1996WO1996026712A2 Use of angiogenesis suppressors for inhibiting hair growth
09/06/1996WO1996026711A1 Nitric oxide synthase inhibitors
09/06/1996WO1996026647A1 Supplement for baby infant formula and a method of delivering that supplement
09/06/1996WO1996021655A3 Substituted oxazolidine calpain and/or cathepsin b inhibitors
09/06/1996WO1996020719A3 Body fluid replacement solution
09/06/1996WO1996020690A3 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
09/06/1996WO1996020209A3 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES
09/06/1996WO1996016647A3 Use of chloride channel blockers for reducing intraocular pressure
09/06/1996CA2214572A1 Novel derivatives of ethyl-1 dihydro-1,2-oxo-2 methylamino-3 quinoxaline, utilization as drugs, and pharmaceutical compositions containing them
09/06/1996CA2214134A1 2-benzyl-3-arylbenzothiophenes
09/06/1996CA2214080A1 Methods of inhibiting ovarian cancer
09/06/1996CA2213971A1 Supplement for baby infant formula and a method of delivering that supplement
09/06/1996CA2213621A1 Antiviral combinations of bch-189 and ritonavir
09/06/1996CA2213563A1 Clavulanic acid salts
09/06/1996CA2213455A1 Controlled release tablet
09/06/1996CA2213388A1 Use of isosorbide-5-mononitrate
09/06/1996CA2213344A1 Use of acid-sensitive organo-transition metal compounds in cancer treatment
09/06/1996CA2213127A1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
09/06/1996CA2212345A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
09/06/1996CA2212294A1 Use of moxonidine for the treatment of atherosclerosis
09/06/1996CA2212101A1 Nitric oxide synthase inhibitors
09/06/1996CA2211706A1 Benzothiopyranoindazoles antitumor agents
09/06/1996CA2189358A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives
09/04/1996EP0730036A1 Process for the enzymatic synthesis of beta-lactam antibiotics in the presence of an enzyme inhibitor
09/04/1996EP0730035A1 Improved enzymatic process for producing penicillins and cephalosporins
09/04/1996EP0730032A2 Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide
09/04/1996EP0729971A1 Method for the preparation of Ivermectin
09/04/1996EP0729964A1 Phosphorous-containing benzothiophenes
09/04/1996EP0729961A1 Clavulanic acid salts
09/04/1996EP0729960A1 Thiophene compounds and their use as intermediates in the preparation of antianxiety drugs, hypnotics, antiepileptic drugs and nuotropics
09/04/1996EP0729958A2 Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinyl-piperazines
09/04/1996EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods
09/04/1996EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome
09/04/1996EP0729954A1 Substituted thiophene sulfonyl ureas and thioureas, process for their preparation, their use as medicaments
09/04/1996EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods
09/04/1996EP0729950A1 Anti-hiv drug
09/04/1996EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
09/04/1996EP0729757A1 Medicament with anti-parasitic activity
09/04/1996EP0729756A1 Granular preparation
09/04/1996EP0729755A2 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer
09/04/1996EP0729754A2 2-Phenyl-3-aroylbonzothiophenes for inhibiting estrogen positive tumors of the brain or CNS
09/04/1996EP0729753A1 Agents for treatment or prevention of hypertension and related symptons and disorders; their preparation and use
09/04/1996EP0729752A2 Central cholecystokinin antagonists having pharmaceutical activity
09/04/1996EP0729751A1 Controlled release formulation containing tramadol
09/04/1996EP0729750A1 Use of an interleukin-1 antagonist and/or alpha-TNF antagonist in a cosmetic, pharmaceutical or dermatological composition, and the composition therefrom, possibly used in combination with a histamine antagonist
09/04/1996EP0729749A1 Pharmaceutical compositions containing dinoreburnamenine derivatives
09/04/1996EP0729745A1 Vitamin C delivery system
09/04/1996EP0729516A1 Recombinant adenoviruses for gene therapy in cancers
09/04/1996EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
09/04/1996EP0729473A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
09/04/1996EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists
09/04/1996EP0729471A1 Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
09/04/1996EP0729469A1 IMIDAZO [1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS
09/04/1996EP0729468A1 Non-peptide tachykinin receptor antagonists
09/04/1996EP0729467A1 Prodrugs of an inhibitor of hiv protease
09/04/1996EP0729466A1 Pyrone derivatives as protease inhibitors and antiviral agents
09/04/1996EP0729465A1 Pyrone derivatives as protease inhibitors and antiviral agents
09/04/1996EP0729464A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
09/04/1996EP0729463A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
09/04/1996EP0729460A1 Substituted 5-ring heterocycles, their preparation and their use
09/04/1996EP0729459A1 Phenyl-alkyl imidazoles as h3-receptor antagonists
09/04/1996EP0729458A1 OCTAHYDROBENZO[f]QUINOLINE-BASED RECEPTOR AGONISTS AND ANTAGONISTS
09/04/1996EP0729457A1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants
09/04/1996EP0729455A1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d
09/04/1996EP0729363A1 Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors
09/04/1996EP0729359A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
09/04/1996EP0729358A1 Transdermal prostaglandin composition
09/04/1996EP0729357A1 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
09/04/1996EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
09/04/1996EP0729354A1 Farnesyl derivatives and pharmaceutical compositions containing them
09/04/1996EP0729353A1 Preparation of biodegradable microparticles containing a biologically active agent
09/04/1996EP0729352A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
09/04/1996EP0729350A1 Hydrophobic preparations
09/04/1996EP0729348A1 Cosmetic method for treatment of skin
09/04/1996EP0729347A1 Cosmetic method for treatment of skin
09/04/1996EP0729346A1 Non-irritating cosmetic compositions
09/04/1996EP0729325A1 Osteogenic product and process
09/04/1996EP0729300A1 Novel fas protein and methods of use thereof
09/04/1996EP0644181B1 Amino acid derivative and use thereof
09/04/1996EP0639197B1 Excitatory amino acid antagonists
09/04/1996EP0636031B1 Vaccine adjuvant
09/04/1996EP0630384A4 Methods and compounds for prevention of graft rejection.
09/04/1996EP0589924B1 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
1 ... 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 ... 7860